DUBLIN, Oct. 8, 2015 /PRNewswire/ -- Perrigo Company
plc (NYSE: PRGO; TASE), announced today that The Hain Celestial
Group, Inc. (Nasdaq: HAIN) through its Earth's Best® brand, has
begun to sell organic infant formula in Hong Kong and China, through Hutchison Hain Organic Holdings
Limited ("HHO"), Hain Celestial's joint venture with Hutchison
China MediTech Limited ("Chi-Med") (LSE AIM: HCM). Chi-Med's
majority owner, CK Hutchison Holdings Limited, is one of the
largest companies in Asia, with a
rich history and core retail business. According to Euromonitor
data, sales of formula in China
exceeded $16.5 billion in 2014.
Perrigo, a top five global over-the-counter (OTC) consumer goods
and pharmaceutical company, is a leading U.S. manufacturer and
supplier of infant formula. Perrigo produces infant formulas for
world markets in FDA-inspected, ISO 9001:2008-certified, cGMP
facilities based in the United States. Hain Celestial is a
leading organic and natural products company with operations in
North American, Europe and
India.
Perrigo's Chairman, President and CEO, Joseph C. Papa stated, "We are excited to
announce the entry of Hain Celestial's Earth's Best Organic® Infant
Formula into the Hong Kong and
Chinese market. Infant formula is a premium product in China, and we believe Earth's Best® organic
formula will be an attractive offering to families in Hong Kong and Mainland China."
"Hain Celestial's Earth's Best Organic® brand continues to grow
in the United States and is well
positioned as a premium organic infant formula brand for Chinese
consumers," said Irwin D. Simon,
Founder, President and Chief Executive Officer of Hain Celestial.
"We are pleased to work with Chi-Med, which has retail
distribution, marketing, and sales support throughout Hong Kong and Mainland China."
Christian Hogg, Chi-Med's CEO,
said: "This exciting collaboration with Hain Celestial and its
Earth's Best® brand, along with our infant formula supplier
Perrigo, to provide Earth's Best Organic® premium, high quality
formula will allow us to leverage our considerable commercial
presence in China against a highly
attractive and fast-growing commercial opportunity. Earth's Best®
is a very recognizable U.S. organic formula brand, and we look
forward to helping grow its distribution and business in
China."
About Perrigo
Perrigo Company plc is a top five global OTC consumer goods and
leading specialty pharmaceutical company, offering patients and
customers high-quality products at affordable prices. From the
Company's beginning in 1887 as a packager of home remedies, it has
grown to become the world's largest manufacturer of OTC healthcare
products and supplier of infant formulas for the store brand
market. The Company is also a leading provider of generic extended
topical prescription products, and it receives royalties from sales
of the multiple sclerosis drug Tysabri®. The Company provides
"Quality Affordable Healthcare Products®" across a wide variety of
product categories and geographies, primarily in North
America, Europe and Australia, as well as in other
markets, including Israel and China. Visit Perrigo
online at (http://www.perrigo.com).
About Hain Celestial
The Hain Celestial Group (NASDAQ: HAIN), headquartered in
Lake Success, NY, is a leading
organic and natural products company with operations in
North America, Europe and India. Hain Celestial
participates in many natural categories with well-known brands that
include Celestial Seasonings®, Earth's Best®, Ella's Kitchen®,
Terra®, Garden of Eatin'®, Sensible Portions®, Health Valley®,
Arrowhead Mills®, MaraNatha®, SunSpire®, DeBoles®, Casbah®, Rudi's
Organic Bakery®, Gluten Free Cafe™, Hain Pure Foods®, Spectrum®,
Spectrum Essentials®, Walnut Acres Organic®, Imagine®, Almond
Dream®, Rice Dream®, Soy Dream®, WestSoy®, The Greek Gods®,
BluePrint®, FreeBird®, Plainville Farms®, Empire Kosher®, Kosher
Valley®, Yves Veggie Cuisine®, Europe's Best®, Cully & Sully®, New Covent
Garden Soup Co.®, Johnson's Juice Co.®, Farmhouse Fare®,
Hartley's®, Sun-Pat®, Gale's®, Robertson's®, Frank Cooper's®, Linda McCartney®, Lima®,
Danival®, Joya®, Natumi®, GG UniqueFiber®, Tilda®, JASON®, Avalon
Organics®, Alba Botanica®, Live Clean® and Queen Helene®.
Hain Celestial has been providing A Healthier Way of Life™ since
1993. For more information, visit www.hain.com.
About Chi-Med
Chi-Med is a China-based
globally-focused healthcare group which researches, develops,
manufactures and sells pharmaceuticals and health-related consumer
products. Its Innovation Platform focuses on discovering and
developing innovative therapeutics in oncology and autoimmune
diseases for the global market. Its Commercial Platform
manufactures, markets, and distributes prescription drugs and
consumer health products in China. Chi-Med is majority owned
by the multinational conglomerate CK Hutchison Holdings Limited
(SEHK: 0001). For more information, please visit:
www.chi-med.com.
Forward-Looking Statements
Certain statements in this presentation are forward-looking
statements within the meaning of Section 21E of the Securities
Exchange Act of 1934, as amended, and are subject to the safe
harbor created thereby. These statements relate to future events or
the Company's future financial performance and involve known and
unknown risks, uncertainties and other factors that may cause the
actual results, levels of activity, performance or achievements of
the Company or its industry to be materially different from those
expressed or implied by any forward-looking statements. In some
cases, forward-looking statements can be identified by terminology
such as "may," "will," "could," "would," "should," "expect,"
"plan," "anticipate," "intend," "believe," "estimate," "predict,"
"potential" or other comparable terminology. The Company has based
these forward-looking statements on its current expectations,
assumptions, estimates and projections. While the Company
believes these expectations, assumptions, estimates and projections
are reasonable, such forward-looking statements are only
predictions and involve known and unknown risks and uncertainties,
many of which are beyond the Company's control. These and other
important factors, including those discussed under "Risk Factors"
in the Perrigo Company's Form 10-K for the year
ended June 28, 2014, as well as the Company's subsequent
filings with the Securities and Exchange Commission, may cause
actual results, performance or achievements to differ materially
from those expressed or implied by these forward-looking
statements. The forward-looking statements in this presentation are
made only as of the date hereof, and unless otherwise required by
applicable securities laws, the Company disclaims any intention or
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or
otherwise.
Logo -
http://photos.prnewswire.com/prnh/20120301/DE62255LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/perrigo-hain-celestial-and-hutchison-china-meditech-bring-earths-best-organic-infant-formula-to-165-billion-china-formula-market-300156610.html
SOURCE Perrigo Company plc